- Tytuł:
- A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer.
- Autorzy:
- Temat:
-
TRASTUZUMAB
EPIDERMAL growth factor receptors
BREAST cancer
CYCLIN-dependent kinase inhibitors
LETROZOLE - Źródło:
- MedComm; Mar2024, Vol. 5 Issue 3, p1-10, 10p
Czasopismo naukowe